BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 883463)

  • 1. Disturbances of fat, carbohydrate, magnesium and protein balance in liver diseases.
    Bojanowicz K; Skarbek-Galamon C
    Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):155-61. PubMed ID: 883463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma and erythrocyte lipids. Relation between globular dystrophies and hepatic lesion in ethylism].
    Garnier M; Gouffier E; Pré J; Jouany JM
    Eur J Toxicol Environ Hyg; 1975; 8(5):298-304. PubMed ID: 1240054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deviations in the level of serum lipids and higher fatty acids in liver cirrhosis and chronic hepatitis].
    Koĭchev K; Vurbanov G
    Vutr Boles; 1977; 16(2):65-71. PubMed ID: 878449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte and plasma lipids in liver diseases.
    Agbedana EO; Ariyo JO; Olubuyide IO; Taylor GO
    Mater Med Pol; 1991; 23(2):117-20. PubMed ID: 1842597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fatty acids in lipid fractions of blood serum in patients with chronic liver diseases].
    Markova MN; Loginov AS
    Ter Arkh; 1975; 47(2):84-92. PubMed ID: 1145465
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum lipids and lipoproteins in chronic liver disease.
    Fehér J; Romics L; Jakab L; Fehér E; Szilvási I; Papp G
    Acta Med Acad Sci Hung; 1976; 33(3):217-23. PubMed ID: 1031549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Total and fractionized plasma phospholipids in chronic liver diseases].
    Cantoni L; Andreuzzi P; Curri SB; Rocchetti P
    Minerva Med; 1975 Jan; 66(3):101-28. PubMed ID: 1118075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic markers of chronic liver disease].
    de Marquez ML; Tombazzi C; Camacho G; Mata M; Carvajal R; Lecuna V
    G E N; 1995; 49(1):1-6. PubMed ID: 8566666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein pattern in acute and chronic liver disease (author's transl)].
    Vogt N; Englhardt A
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2156-60. PubMed ID: 170052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
    Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The behavior of lipids in acute viral hepatitis and chronic hepatopathies].
    Boroń-Kaczmarska A; Lapiński W
    Z Gesamte Inn Med; 1988 May; 43(9):225-8. PubMed ID: 3136599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in plasma lipids and lipoproteins in chronic liver diseases].
    Cavanna A; Tappero R; Brizio T; Griffa G; Garlanda PF; Molino G
    Quad Sclavo Diagn; 1981 Dec; 17(4):553-6. PubMed ID: 7347833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver and blood protein-carbohydrate].
    Kerschbaumer FW
    Wien Klin Wochenschr; 1970 May; 82(18):333-7. PubMed ID: 5516064
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid metabolism and parenteral fat administration in liver failure].
    Holm E; Staedt U; Leweling H; Bässler KH; Specker M; Tschepe A
    Infusionsther Klin Ernahr; 1983 Aug; 10(4):184-204. PubMed ID: 6618659
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of serum HCV core concentration with blood level of lipid and antioxidants in various forms of liver diseases.
    Irshad M; Dhar I; Gupta S; Khushboo ; Joshi YK
    Hepatogastroenterology; 2007; 54(75):898-902. PubMed ID: 17591087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basis for the pathogenetic diet therapy of chronic liver diseases in children].
    Nevskaia TS; Pinzur ED; Zubrilina GV; Chistova LV
    Vopr Pitan; 1971; 30(2):50-5. PubMed ID: 5137214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of plasma lipids in patients with liver cirrhosis and hepatitis].
    Platzer S; Sailer S; Sandhofer F; Braunsteiner H
    Wien Klin Wochenschr; 1966 Jan; 78(4):56-8. PubMed ID: 5962258
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.